ArticlePlastic and reconstructive surgery. Global open2026
Shifting Practice Patterns in Implant-based Breast Reconstruction in China: Insights From a 13-year Large-scale Retrospective Cohort.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Implant-based breast reconstruction (IBBR) has become the leading method for postmastectomy reconstruction worldwide. In China, growing patient demand has driven increased use of IBBR, but national trends in techniques and outcomes remain underreported. This study aimed to evaluate the evolution of IBBR practices and associated outcomes during a 13-year period at China's largest breast cancer center. Methods: We retrospectively analyzed 6088 patients who underwent breast reconstruction at Fudan University Shanghai Cancer Center from 2010 to 2023. We examined trends in surgical timing, reconstruction type (direct-to-implant [DTI] versus 2-stage tissue expander [TE]), mastectomy type, implant placement (prepectoral versus subpectoral), TiLOOP Bra use, postmastectomy radiotherapy, and unplanned reoperations. Logistic regression identified factors associated with DTI selection and reoperation risk. Results: The proportion of patients undergoing mastectomy receiving reconstruction rose from 5.3% in 2010 to 16.7% in 2023. IBBR became the predominant method after 2015, comprising 70%-80% of reconstructions since 2017. DTI surpassed TE in 2023, accounting for 73.4% of implant cases. DTI reconstruction was independently associated with nipple-sparing mastectomy, TiLOOP Bra use, and prepectoral placement. TiLOOP use significantly reduced reoperation risk (odds ratio = 0.63, Conclusions: IBBR in China has rapidly evolved, with DTI and TiLOOP Bra use driving improved surgical outcomes. These findings support the growing role of surgical innovation, mesh support, and individualized planning in modern breast reconstruction.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.